Critical care nephrology: Management of acid-base disorders with CRRT

Kidney International

Volumn 82, Issue 1, 2012, Pages 9-18

  Cerdá, Jorge ^a   Tolwani, Ashita J ^b   Warnock, David G ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

acid base disorders; continuous renal replacement therapies; critical care nephrology; hypercapnic acidosis; lactic acidosis

Indexed keywords

BICARBONATE; CARBICARB; CARNITINE; CITRIC ACID; DICHLOROACETIC ACID; METFORMIN; PHENFORMIN; PLACEBO; RIBOFLAVIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SODIUM CHLORIDE; THIAMINE;

ACIDEMIA; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ARTIFICIAL VENTILATION; BAROTRAUMA; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DISORDERS OF ACID BASE BALANCE; DRUG EFFECT; DRUG ELIMINATION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPERCAPNIC ACIDOSIS; INTENSIVE CARE; LACTIC ACIDOSIS; LUNG ALVEOLUS HYPOVENTILATION; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; NONHUMAN; NONINVASIVE VENTILATION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY ACIDOSIS; RESPIRATORY FAILURE; REVIEW; SEPSIS;

EID: 84862505761     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.243     Document Type: Article

References (156)

1. Bernard C. Lectures on the Phenomena of Life Common to Animals and Plants. (translated: original work published in 1878) Charles C. Thomas: Springfield, IL, 1974.
2. Adrogue HJ, Madias NE. Secondary responses to altered acid-base status: the rules of engagement. J Am Soc Nephrol 2010; 21: 920-923.
3. Cerda J, Ronco C. Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 2009; 22: 114-122.
4. Adrogue HJ, Gennari FJ, Galla JH et al. Assessing acid-base disorders. Kidney Int 2009; 76: 1239-1247.
5. Gunnerson KJ, Kellum JA. Acid-base and electrolyte analysis in critically ill patients: are we ready for the new millennium? Curr Opin Crit Care 2003; 9: 468-473. (Pubitemid 37518645)
6. Kellum JA. Disorders of acid-base balance. Crit Care Med 2007; 35: 2630-2636. (Pubitemid 351339027)
7. Kurtz I, Kraut J, Ornekian V et al. Acid-base analysis: a critique of the Stewart and bicarbonate-centered approaches. Am J Physiol Renal Physiol 2008; 294: F1009-F1031.
8. Crosby A, Talbot NP, Balanos GM et al. Respiratory effects in humans of a 5-day elevation of end-tidal PCO2 by 8 Torr. J Appl Physiol 2003; 95: 1947-1954. (Pubitemid 37310379)
9. Mitchell RA, Singer MM. Respiration and cerebrospinal fluid pH in metabolic acidosis and alkalosis. J Appl Physiol 1965; 20: 905-911.
10. Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693. (Pubitemid 41464707)
11. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials NetworkWiedemann HP, Wheeler AP et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575.
12. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824. (Pubitemid 24082248)
13. Cerda J, Sheinfeld G, Ronco C. Fluid overload in critically ill patients with acute kidney injury. Blood Purif 2010; 29: 11-18.
14. Hoste EA, De Corte W. Epidemiology of AKI in the ICU. Acta Clin Belg Suppl 2007; 2: S314-S317.
15. Cerda J, Lameire N, Eggers P et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 881-886.
16. Yohannes S, Chawla LS. Evolving practices in the management of acute kidney injury in the ICU (Intensive Care Unit). Clin Nephrol 2009; 71: 602-607.
17. Liu KD, Matthay MA, Chertow GM. Evolving practices in critical care and potential implications for management of acute kidney injury. Clin J Am Soc Nephrol 2006; 1: 869-873.
18. Graf H, Leach W, Arieff AI. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science 1985; 227: 754-756. (Pubitemid 15168262)
19. Frank JA, Parsons PE, Matthay MA. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006; 130: 1906-1914. (Pubitemid 46033452)
20. Higgins BD, Costello J, Contreras M et al. Differential effects of buffered hypercapnia versus hypercapnic acidosis on shock and lung injury induced by systemic sepsis. Anesthesiology 2009; 111: 1317-1326.
21. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
22. Brower RG, Lanken PN, MacIntyre N et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327-336.
23. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16: 372-377. (Pubitemid 20321485)
24. Brower RG, Ware LB, Berthiaume Y et al. Treatment of ARDS. Chest 2001; 120: 1347-1367. (Pubitemid 32960113)
25. Kallet RH, Liu K, Tang J. Management of acidosis during lung-protective ventilation in acute respiratory distress syndrome. Respir Care Clin N Am 2003; 9: 437-456. (Pubitemid 37540428)
26. Petrucci N, Iacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2007: CD003844.
27. Ijland MM, Heunks LM, van der Hoeven JG. Bench-to-bedside review: hypercapnic acidosis in lung injury - from 'permissive' to 'therapeutic'. Crit Care 2010; 14: 237.
28. Potkin RT, Swenson ER. Resuscitation from severe acute hypercapnia. Determinants of tolerance and survival. Chest 1992; 102: 1742-1745. (Pubitemid 23001219)
29. Swenson ER. Sepsis and therapeutic hypercapnia: sailing too close to the wind? Anesthesiology 2010; 112: 269-271.
30. Swenson ER. Metabolic acidosis. Respir Care 2001; 46: 342-353. (Pubitemid 33762006)
31. Li X, Hassoun HT, Santora R et al. Organ crosstalk: the role of the kidney. Curr Opin Crit Care 2009; 15: 481-487.
32. Feihl F, Perret C. Permissive hypercapnia. How permissive should we be? Am J Respir Crit Care Med 1994; 150: 1722-1737.
33. Shiota S, Okada T, Naitoh H et al. Hypoxia and hypercapnia affect contractile and histological properties of rat diaphragm and hind limb muscles. Pathophysiology 2004; 11: 23-30. (Pubitemid 38721309)
34. Laffey JG, O'Croinin D, McLoughlin P et al. Permissive hypercapnia-role in protective lung ventilatory strategies. Intensive Care Med 2004; 30: 347-356. (Pubitemid 38375607)
35. Doerr CH, Gajic O, Berrios JC et al. Hypercapnic acidosis impairs plasma membrane wound resealing in ventilator-injured lungs. Am J Respir Crit Care Med 2005; 171: 1371-1377. (Pubitemid 40800509)
36. Vadasz I, Dada LA, Briva A et al. AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis. J Clin Invest 2008; 118: 752-762. (Pubitemid 351206563)
37. Costello J, Higgins B, Contreras M et al. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit Care Med 2009; 37: 2412-2420.
38. Curley G, Contreras MM, Nichol AD et al. Hypercapnia and acidosis in sepsis: a double-edged sword? Anesthesiology 2010; 112: 462-472.
39. Hickling KG, Walsh J, Henderson S et al. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994; 22: 1568-1578. (Pubitemid 24320879)
40. Kregenow DA, Rubenfeld GD, Hudson LD et al. Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med 2006; 34: 1-7. (Pubitemid 43032373)
41. Ni Chonghaile M, Higgins B, Laffey JG. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care 2005; 11: 56-62. (Pubitemid 40223720)
42. Nichol AD, O'Cronin DF, Naughton F et al. Hypercapnic acidosis reduces oxidative reactions in endotoxin-induced lung injury. Anesthesiology 2010; 113: 116-125.
43. Sanz AB, Sanchez-Nino MD, Ramos AM et al. NF-kappaB in renal inflammation. J Am Soc Nephrol 2010; 21: 1254-1262.
44. Choi WI, Quinn DA, Park KM et al. Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am J Respir Crit Care Med 2003; 167: 1627-1632. (Pubitemid 36760675)
45. Chien CC, King LS, Rabb H. Mechanisms underlying combined acute renal failure and acute lung injury in the intensive care unit. Contrib Nephrol 2004; 144: 53-62.
46. Kuiper JW, Groeneveld AB, Slutsky AS et al. Mechanical ventilation and acute renal failure. Crit Care Med 2005; 33: 1408-1415. (Pubitemid 40827397)
47. 3 in experimental lactic acidosis in dogs. Am J Physiol 1982; 242: F586-F591.
48. Cooper DJ, Walley KR, Wiggs BR et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 1990; 112: 492-498. (Pubitemid 20100286)
49. Goldsmith DJ, Forni LG, Hilton PJ. Bicarbonate therapy and intracellular acidosis. Clin Sci (Lond) 1997; 93: 593-598. (Pubitemid 27517295)
50. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000; 117: 260-267. (Pubitemid 30053648)
51. Li YC, Wiklund L, Tarkkila P et al. Influence of alkaline buffers on cytoplasmic pH in myocardial cells exposed to metabolic acidosis. Resuscitation 1996; 32: 33-44. (Pubitemid 26178261)
52. Mathieu D, Neviere R, Billard V et al. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 1991; 19: 1352-1356.
53. Tzanatos H, Dalamangas A, Retsa K et al. Relation of interdialytic water retention with apparent bicarbonate space, HCO3-, and pH in hemodialyzed uremic patients. Ren Fail 2005; 27: 235-238. (Pubitemid 40393138)
54. Symreng T, Flanigan MJ, Lim VS. Ventilatory and metabolic changes during high efficiency hemodialysis. Kidney Int 1992; 41: 1064-1069.
55. Eschelbacher D, Chawla L, Lew S. Correction of respiratory acidosis by continuous renal replacement therapy. J Appl Res 2004; 4: 228-233. (Pubitemid 39387298)
56. Cressoni M, Zanella A, Epp M et al. Decreasing pulmonary ventilation through bicarbonate ultrafiltration: an experimental study. Crit Care Med 2009; 37: 2612-2618.
57. Tolwani AJ, Campbell RC, Schenk MB et al. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60: 370-374. (Pubitemid 32587577)
58. Tolwani A, Wille KM. Citrate-based replacement solutions with continuous venovenous hemofiltration: not as simple as it sounds. Am J Kidney Dis 2006; 47: 1086; author reply 1086-1087.
59. Boyd JH, Walley KR. Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care 2008; 14: 379-383.
60. Mehta RL. Indications for dialysis in the ICU: renal replacement vs. renal support. Blood Purif 2001; 19: 227-232. (Pubitemid 32041359)
61. Livigni S, Maio M, Ferretti E et al. Efficacy and safety of a low-flow venovenous carbon dioxide removal device: results of an experimental study in adult sheep. Crit Care 2006; 10: R151.
62. Bein T, Weber F, Philipp A et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 2006; 34: 1372-1377.
63. Terragni PP, Birocco A, Faggiano C et al. Extracorporeal CO2 removal. Contrib Nephrol 2010; 165: 185-196.
64. Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol 2001; 12(Suppl 17): S15-S19. (Pubitemid 32119049)
65. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 2010; 6: 274-285.
66. Vernon C, Letourneau JL. Lactic acidosis: recognition, kinetics, and associated prognosis. Crit Care Clin 2010; 26: 255-283.
67. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
68. Nguyen HB, Rivers EP, Knoblich BP et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32: 1637-1642. (Pubitemid 39050511)
69. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
70. Polonen P, Ruokonen E, Hippelainen M et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 2000; 90: 1052-1059. (Pubitemid 30253449)
71. Jansen TC, van Bommel J, Schoonderbeek FJ et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 752-761.
72. Gauthier PM, Szerlip HM. Metabolic acidosis in the intensive care unit. Crit Care Clin 2002; 18: 289-308. (Pubitemid 34556514)
73. Cohen RD, Woods HF. Lactic acidosis revisited. Diabetes 1983; 32: 181-191. (Pubitemid 13180353)
74. Bellomo R. Bench-to-bedside review: lactate and the kidney. Crit Care 2002; 6: 322-326. (Pubitemid 34863699)
75. Arieff AI, Park R, Leach WJ et al. Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol 1980; 239: F135-F142.
76. Yudkin J, Cohen RD. The effect of acidosis on lactate removal by the perfused rat kidney. Clin Sci Mol Med 1976; 50: 185-194.
77. Gore DC, Jahoor F, Hibbert JM et al. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 224: 97-102. (Pubitemid 26230130)
78. James JH, Luchette FA, McCarter FD et al. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999; 354: 505-508. (Pubitemid 29368940)
79. Singer M, Brealey D. Mitochondrial dysfunction in sepsis. Biochem Soc Symp 1999; 66: 149-166. (Pubitemid 129639030)
80. Brealey D, Brand M, Hargreaves I et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360: 219-223. (Pubitemid 34804650)
81. Callahan LA, Supinski GS. Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 2005; 172: 861-868. (Pubitemid 41369070)
82. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care 2006; 12: 315-321. (Pubitemid 44078143)
83. Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med 2003; 348: 86-87.
84. Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med 2005; 353: 2305-2306.
85. De Vriese AS, Coster RV, Smet J et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006; 42: 1111-1117.
86. Gan SC, Barr J, Arieff AI et al. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med 1992; 152: 2333-2336.
87. Wiener M, Guo Y, Patel G et al. Lactic acidosis after treatment with linezolid. Infection 2007; 35: 278-281. (Pubitemid 47222283)
88. Stacpoole PW, Wright EC, Baumgartner TG et al. Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med 1994; 97: 47-54. (Pubitemid 24223633)
89. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004; 558: 5-30. (Pubitemid 39077388)
90. Levraut J, Ciebiera JP, Chave S et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998; 157: 1021-1026.
91. Kellum JA, Kramer DJ, Lee K et al. Release of lactate by the lung in acute lung injury. Chest 1997; 111: 1301-1305. (Pubitemid 27200089)
92. Vary TC, Hazen S. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem 1999; 198: 113-118. (Pubitemid 29414529)
93. Chrusch C, Bands C, Bose D et al. Impaired hepatic extraction and increased splanchnic production contribute to lactic acidosis in canine sepsis. Am J Respir Crit Care Med 2000; 161: 517-526. (Pubitemid 30129462)
94. Severin PN, Uhing MR, Beno DW et al. Endotoxin-induced hyperlactatemia results from decreased lactate clearance in hemodynamically stable rats. Crit Care Med 2002; 30: 2509-2514. (Pubitemid 35351871)
95. Stacpoole PW, Harman EM, Curry SH et al. Treatment of lactic acidosis with dichloroacetate. N Engl J Med 1983; 309: 390-396. (Pubitemid 13033963)
96. Stacpoole PW, Nagaraja NV, Hutson AD. Efficacy of dichloroacetate as a lactate-lowering drug. J Clin Pharmacol 2003; 43: 683-691. (Pubitemid 36759145)
97. Zahler R, Barrett E, Majumdar S et al. Lactic acidosis: effect of treatment on intracellular pH and energetics in living rat heart. Am J Physiol 1992; 262: H1572-H1578.
98. Benjamin E, Oropello JM, Abalos AM et al. Effects of acid-base correction on hemodynamics, oxygen dynamics, and resuscitability in severe canine hemorrhagic shock. Crit Care Med 1994; 22: 1616-1623. (Pubitemid 24320886)
99. Park R, Arieff AI. Treatment of lactic acidosis with dichloroacetate in dogs. J Clin Invest 1982; 70: 853-862. (Pubitemid 12038102)
100. Kraut JA, Kurtz I. Use of base in the treatment of acute severe organic acidosis by nephrologists and critical care physicians: results of an online survey. Clin Exp Nephrol 2006; 10: 111-117. (Pubitemid 43961603)
101. Sabatini S, Kurtzman NA. Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol 2009; 20: 692-695.
102. 3 for the treatment of acidosis. Surgery 1987; 102: 835-839.
103. Bersin RM, Arieff AI. Improved hemodynamic function during hypoxia with Carbicarb, a new agent for the management of acidosis. Circulation 1988; 77: 227-233. (Pubitemid 18031019)
104. Klepper ID, Kucera RF, Kindig NB et al. A comparative study of sodium bicarbonate and carbicarb in the treatment of metabolic acidosis induced by hemorrhagic shock. J Crit Care 1988; 3: 256-261. (Pubitemid 19003674)
105. Rhee KH, Toro LO, McDonald GG et al. Carbicarb, sodium bicarbonate, and sodium chloride in hypoxic lactic acidosis. Effect on arterial blood gases, lactate concentrations, hemodynamic variables, and myocardial intracellular pH. Chest 1993; 104: 913-918. (Pubitemid 23268970)
106. Stacpoole PW, Wright EC, Baumgartner TG et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med 1992; 327: 1564-1569.
107. Barton IK, Streather CP, Hilton PJ et al. Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. Nephrol Dial Transplant 1991; 6: 368-370.
108. Kirschbaum B, Galishoff M, Reines HD. Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation. Crit Care Med 1992; 20: 349-353.
109. Schetz M. Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 1999; 72: S88-S94.
110. Hilton PJ, Taylor J, Forni LG et al. Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. QJM 1998; 91: 279-283. (Pubitemid 28161909)
111. Uchino S, Bellomo R, Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance. Intensive Care Med 2001; 27: 1037-1043. (Pubitemid 32662486)
112. Baldwin I, Naka T, Koch B et al. A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med 2007; 33: 830-835. (Pubitemid 46675330)
113. Levraut J, Ciebiera JP, Jambou P et al. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 1997; 25: 58-62.
114. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4059-4067. (Pubitemid 26380418)
115. Salpeter SR, Greyber E, Pasternak GA et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010: CD002967.
116. Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999; 20: 377-384.
117. Peters N, Jay N, Barraud D et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care 2008; 12: R149.
118. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994; 30: 187-228. (Pubitemid 24365533)
119. Assan R, Heuclin C, Ganeval D et al. Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia 1977; 13: 211-217. (Pubitemid 8109385)
120. Misbin RI, Green L, Stadel BV et al. Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 1998; 338: 265-266. (Pubitemid 28047587)
121. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999; 22: 925-927. (Pubitemid 29241046)
122. Seidowsky A, Nseir S, Houdret N et al. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009; 37: 2191-2196.
123. Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996; 30: 359-371. (Pubitemid 26177181)
124. Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 2002; 40: 177-180. (Pubitemid 34755585)
125. Panzer U, Kluge S, Kreymann G et al. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant 2004; 19: 2157-2158. (Pubitemid 39139660)
126. Friesecke S, Abel P, Kraft M et al. Combined renal replacement therapy for severe metformin-induced lactic acidosis. Nephrol Dial Transplant 2006; 21: 2038-2039. (Pubitemid 43985760)
127. Alivanis P, Giannikouris I, Paliuras C et al. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther 2006; 28: 396-400. (Pubitemid 43783435)
128. Prikis M, Mesler EL, Hood VL et al. When a friend can become an enemy! Recognition and management of metformin-associated lactic acidosis. Kidney Int 2007; 72: 1157-1160. (Pubitemid 47609030)
129. Di Grande A, Vancheri F, Giustolisi V et al. Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure. Clinica terapeutica 2008; 159: 87-89. (Pubitemid 351678191)
130. Perrone J, Phillips C, Gaieski D. Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med 2011; 40(Suppl 3): S271-S275.
131. Ashall V, Dawes T. Metformin and lactic acidosis. Br J Anaesth 2008; 101: 876-877.
132. Bruijstens LA, van Luin M, Buscher-Jungerhans PM et al. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment. Neth J Med 2008; 66: 185-190. (Pubitemid 351771998)
133. Fitzgerald E, Mathieu S, Ball A. Metformin associated lactic acidosis. BMJ 2009; 339: b3660.
134. Pan LT, MacLaren G. Continuous venovenous haemodiafiltration for metformin-induced lactic acidosis. Anaesth Intensive Care 2009; 37: 830-832.
135. Arroyo AM, Walroth TA, Mowry JB et al. The MALAdy of metformin poisoning: Is CVVH the cure? Am J Ther 2010; 17: 96-100.
136. Devetzis V, Passadakis P, Panagoutsos S et al. Metformin-related lactic acidosis in patients with acute kidney injury. Int Urol Nephrol 22 September 2010 (e-pub ahead of print).
137. Guo PY, Storsley LJ, Finkle SN. Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial 2006; 19: 80-83. (Pubitemid 43479015)
138. Protti A, Russo R, Tagliabue P et al. Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication. Crit Care 2010; 14: R22.
139. Claessens YE, Chiche JD, Mira JP et al. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Crit Care 2003; 7: 226-232.
140. Fouty B, Frerman F, Reves R. Riboflavin to treat nucleoside analogueinduced lactic acidosis. Lancet 1998; 352: 291-292. (Pubitemid 28340157)
141. Arici C, Tebaldi A, Quinzan GP et al. Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART. Int J STD AIDS 2001; 12: 407-409. (Pubitemid 32538882)
142. Hirose Y, Miida T, Yoshida K et al. High-output heart failure in mitochondrial myopathy: a fulminant form with severe lactic acidosis and rhabdomyolysis. Intern Med 1993; 32: 798-801.
143. Bissuel F, Bruneel F, Habersetzer F et al. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med 1994; 235: 367-371.
144. Roy PM, Gouello JP, Pennison-Besnier I et al. Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man. Ann Emerg Med 1999; 34: 282-284. (Pubitemid 29361881)
145. Chodock R, Mylonakis E, Shemin D et al. Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis-role of haemodialysis treatment. Nephrol Dial Transplant 1999; 14: 2484-2486. (Pubitemid 29462494)
146. Vasseur BG, Kawanishi H, Shah N et al. Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery. Ann Thorac Surg 2002; 74: 1251-1252. (Pubitemid 35176764)
147. Bonnet F, Bonarek M, Morlat P et al. Risk factors for lactic acidosis in HIVinfected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study. Clin Infect Dis 2003; 36: 1324-1328. (Pubitemid 36629944)
148. Tolwani AJ, Prendergast MB, Speer RR et al. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1: 79-87.
149. Hamm LL. Renal handling of citrate. Kidney Int 1990; 38: 728-735. (Pubitemid 20299427)
150. Kutsogiannis DJ, Mayers I, Chin WD et al. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 35: 802-811. (Pubitemid 30238190)
151. Calatzis A, Toepfer M, Schramm W et al. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 2001; 89: 233-236. (Pubitemid 32830617)
152. Apsner R, Schwarzenhofer M, Derfler K et al. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997; 109: 123-127. (Pubitemid 27128454)
153. Meier-Kriesche HU, Gitomer J, Finkel K et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29: 748-752. (Pubitemid 32299711)
154. Kramer L, Bauer E, Joukhadar C et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31: 2450-2455. (Pubitemid 37281728)
155. Bakker AJ, Boerma EC, Keidel H et al. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 2006; 44: 962-966. (Pubitemid 44155864)
156. Feriani M. Tailoring peritoneal dialysis fluid for optimal acid-base targets. Contrib Nephrol 2009; 163: 67-73.